Groupe pharmaceutique · Israël
Teva
Un groupe de 87 sociétés, avec 6 348 médicaments dans 12 pays.
Structure du groupe
87 sociétés dans 24 pays
Chargement de votre page…
Chargement de votre page…
Groupe pharmaceutique · Israël
Un groupe de 87 sociétés, avec 6 348 médicaments dans 12 pays.
87 sociétés dans 24 pays
Un compte gratuit pour les apps Prognia : Ward pour réviser, Osler pour des réponses cliniques avec leurs sources, et le réseau pour retrouver vos collègues.
Les groupes sont constitués par Prognia à partir des noms publiés par les autorités et des liens entre sociétés ; ils ne reflètent pas une structure juridique officielle.
Tous les médicaments de toutes les sociétés du groupe, les actuels d’abord.
1–25 sur 6 348
| Médicament | Substance active | Pays | Statut | Autorisation |
|---|---|---|---|---|
| ABACAVIR/LAMIVUDINA TEVA 600 MG/300 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG600 mg + 300 mg · Comprimido recubierto con película | Abacavir, Lamivudine | Espagne | Commercialisé | 2016 |
| Abacavir/Lamivudine Teva 600/300 mg, filmomhulde tablettenFilmomhulde tablet | Abacavir, Lamivudine | Pays-Bas | Autorisé | 2016 |
| Abakavir/lamivudin Pliva 600 mg/300 mg filmom obložene tablete*filmom obložena tableta | Abacavir, Lamivudine | Croatie | Non commercialisé | 2020 |
| Abelcet lipid complex 5 mg/ml koncentrat za disperziju za infuziju*koncentrat za disperziju za infuziju | Amphotericin b | Croatie | Non commercialisé | 2019 |
| Abirateron Teva500mg · film tableta | Abiraterone | Serbie | Autorisé | 2023 |
| Abirateron Teva500mg · film tableta | Abiraterone | Serbie | Autorisé | 2023 |
| Abirateron Teva500mg · film tableta | Abiraterone | Serbie | Autorisé | 2023 |
| Abirateron Teva 500 mg filmom obložene tableteFilmom obložena tableta | Abiraterone | Croatie | Commercialisé | 2022 |
| Abirateron Teva 500 mg, filmomhulde tablettenFilmomhulde tablet | Abiraterone | Pays-Bas | Autorisé | 2022 |
| ABIRATERONE-TEVA FC TABLET 250 MG250 mg · Tablet, film coated | Abiraterone | Singapour | Autorisé | 2022 |
| ABIRATERONE-TEVA FC TABLET 500 MG500 mg · Tablet, film coated | Abiraterone | Singapour | Autorisé | 2024 |
| ACETAMINOPHEN325 mg · Tablet | Paracetamol | Canada | Autorisé | |
| ACETAMINOPHEN AND CODEINE PHOSPHATE300mg; 15mg | 300mg; 30mg | 300mg; 60mg · Capsule | Paracetamol, Codeine | États-Unis | Non commercialisé | 1983 |
| ACETAMINOPHEN EXTRA STRENGTH500 mg · Tablet | Paracetamol | Canada | Autorisé | |
| ACETAMINOPHEN WITH CODEINE - CAPLET300 mg + 15 mg + 8 mg · Tablet | Paracetamol, Caffeine, Codeine | Canada | Commercialisé | 1997 |
| ACETASOL2% · Solution/drops | Acetic acid, Glacial | États-Unis | Non commercialisé | 1981 |
| ACETASOL HC2%; 1% · Solution/drops | Acetic acid, Glacial, Hydrocortisone | États-Unis | Non commercialisé | 1982 |
| acetato de abiraterona | Abiraterone | Brésil | Autorisé | 2020 |
| acetato de glatirâmer | Glatiramer acetate | Brésil | Autorisé | 2023 |
| ACETILCISTEINA RATIOPHARMCompressa effervescente | Acetylcysteine | Italie | Autorisé | |
| ACETILCISTEINA TEVA-RATIOPHARM 200 MG POLVO PARA SOLUCION ORAL EFG200 mg · Polvo para solución oral | Acetylcysteine | Espagne | Commercialisé | 2000 |
| ACETILCISTEINA TEVA-RATIOPHARM 600 mg COMPRIMIDOS EFERVESCENTES EFG600 mg · Comprimido efervescente | Acetylcysteine | Espagne | Commercialisé | 2000 |
| Acetylcysteine bruis Teva 200 mg, bruistablettenBruistablet | Acetylcysteine | Pays-Bas | Autorisé | 1992 |
| Acetylcysteine bruis Teva 600 mg, bruistablettenBruistablet | Acetylcysteine | Pays-Bas | Autorisé | 1992 |
| Acetylcysteïne Teva 200 mg, poeder voor oraal gebruikPoeder voor oraal gebruik | Acetylcysteine | Pays-Bas | Autorisé | 1988 |
Où ses médicaments sont enregistrés ou fabriqués, et combien sont actuels.
| Pays | Médicaments | Actuels | Anciens | Sociétés |
|---|---|---|---|---|
| Canada | 1 853 | 708 | 1 145 | SociétésTous les médicaments |
| Espagne | 1 382 | 903 | 479 | SociétésTous les médicaments |
| Pays-Bas | 1 072 | 1 072 | 0 | SociétésTous les médicaments |
| Croatie | 414 | 414 | 0 | SociétésTous les médicaments |
| Italie | 381 | 381 | 0 | SociétésTous les médicaments |
| Serbie | 326 | 319 | 7 | SociétésTous les médicaments |
| États-Unis | 313 | 283 | 30 | SociétésTous les médicaments |
| Roumanie | 227 | 0 | 227 | SociétésTous les médicaments |
| Singapour | 149 | 149 | 0 | SociétésTous les médicaments |
| Union européenne (EMA) | 105 | 62 | 43 | SociétésTous les médicaments |
| Brésil | 72 | 41 | 31 | SociétésTous les médicaments |
| Arabie saoudite | 54 | 54 | 0 | SociétésTous les médicaments |
Également dans les registres : France, Royaume-Uni
Les groupes ATC auxquels appartiennent la plupart de ses médicaments, les plus importants d’abord.
Les substances actives présentes dans la plupart de ses médicaments.
Comment les registres l’écrivent, normalisé : sans forme juridique, accents ni majuscules.
Compilé par Prognia à partir des registres publics de médicaments et d’entreprises ci-dessous. Aucun logo n’est utilisé.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence : EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence : AEMPS open data reuse with attribution
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence : Public domain (U.S. Government work)
Source: BDPM (ANSM, HAS, UNCAM).
Licence : Licence Ouverte v1.0
ANVISA / CMED, consumer price table; embedded source date 2026-07-21 and retrieval date
Licence : Other (Public Domain)
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence : Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence : Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence : Open Government Licence Canada
Czech Ministry of Finance, ARES; Ministry of Justice commercial register (VR), Czech Statistical Office (RES), exact IČO, source record datumAktualizace and retrieval date. Structured extraction by Prognia.
Licence : Czech statutory open data; ARES reuse and operating terms
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence : AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence : BDPM exact Licence Ouverte v1.0 (October 2011)
INSEE (www.insee.fr), via DINUM API Recherche d’entreprises; include original record update date and retrieval date
Licence : Licence Ouverte / Open Licence
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence : Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence : Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence : CC BY 4.0; AIFA published open-data catalog
Ministero della Salute, Italy; https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; original CSV snapshot 15 October 2026, acquired 2026-10-15T13:26:43.659718+00:00; adapted factual fields under IODL2. Coordinates: © OpenStreetMap contributors, separate rights gate.
Licence : Italian Open Data Licence v2.0, exact dataset-catalog assignment; coordinate fields separately attributed to OpenStreetMap
Ministero della Salute, Distributori di farmaci, source file13Oct2026. https://www.dati.salute.gov.it/it/dataset/distributori-di-farmaci/; IODL2.0 https://www.dati.gov.it/content/italian-open-data-license-v20. Original URLs/locators and retrieval timestamps; selected/normalized by Prognia; no government endorsement.
Licence : Italian Open Data Licence
State Enterprise Centre of Registers / Valstybės įmonė Registrų centras; source dataset/resource URL, exact original code/UUID/revision, original CSV ordinal, retrieval time; CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; selected field normalization by Prognia.
Licence : Creative Commons Attribution
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence : Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Contains data under the Norwegian licence for Open Government data (NLOD) distributed by Brønnøysundregistrene. https://data.norge.no/nlod/en/2.0; original API URLs, retrieval dates and locators. Selected and normalized by Prognia; fractional JSON numbers preserved as labelled exact decimal strings.
Licence : Norwegian Licence for Open Government Data
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence : Creative Commons Attribution 4.0 International (CC BY 4.0)
Oficiul Național al Registrului Comerțului; exact original source URLs, snapshot2026-09-02 where applicable, retrieval date, original record locators; https://creativecommons.org/licenses/by/4.0/
Licence : Creative Commons Attribution
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence : Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence : Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence : Singapore Open Data Licence
Register právnických osôb, podnikateľov a orgánov verejnej moci; public API licence names Štatistický úrad Slovenskej republiky; administration transferred to Ministerstvo vnútra SR; original API URL, literal identifier and source locators, source version and retrieval date; https://creativecommons.org/licenses/by/4.0/; normalization identified.
Licence : Creative Commons Attribution
Slovak Ministry of Finance, Register účtovných závierok (RÚZ) Open API; exact IČO/accounting-unit, filing, report and template IDs; original API URLs, source locators and retrieval dates; https://www.registeruz.sk/cruz-public/home/api; extraction/normalization stated.
Licence : CC0
FDA Purple Book, September 2026 release; acquired 2026-10-10T15:29:54.330165+00:00; exact source fields retained with source-key projections.
Licence : FDA-created structured factual administrative metadata; public-domain policy with third-party exceptions
Signaler une erreur ou demander un retraitLes corrections de la société elle-même sont les bienvenues.
Teva : veillez à l’exactitude de vos médicaments sur Prognia, voyez comment les professionnels les utilisent et répondez à leurs questions. Un appel de 20 minutes, en anglais.
Réserver un appelDes groupes pharmaceutiques connus, chacun avec toutes ses sociétés.